- ￥1880
- 晶风生物
- TF20209R
- 中国
- 2025年07月14日
- Elisa=1:500-1000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ICC=1:100-500,
- Rabbit
- Human,Mouse,Rat,Dog,Pig,Cow,Rabbit,Sheep,Guinea Pig,
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 抗体名：
异常凝血酶原/脱-γ-羧基凝血酶原抗体
- 抗体英文名：
DCP
- 靶点：
细胞浆 细胞膜 分泌型蛋白
- 浓度：
1mg/ml
- 应用范围：
Elisa=1:500-1000,IHC-P=1:100-500,IHC-F=1:100-500,IF=1:100-500,ICC=1:100-500,
- 宿主：
Rabbit
- 适应物种：
Human,Mouse,Rat,Dog,Pig,Cow,Rabbit,Sheep,Guinea Pig,
- 保质期：
一年
- 抗原来源：
Rabbit
- 目录编号：
TF20209R
- 级别：
I级
- 库存：
10
- 供应商：
晶风生物
- 标记物：
FITC/Alexa/CY357/BIo/HRP
- 克隆性：
Polyclonal
- 保存条件：
-20
- 形态：
Liquid
- 亚型：
IgG
- 免疫原：
KLH conjugated synthetic peptide derived
- 规格：
50ul/100ul/200ul
产品规格：100ul/200ul(部分有50ul，如需更大包装或其他具体规格，请咨询客服)
研究领域：肿瘤 细胞生物 免疫学等
抗体来源：Rabbit
克隆类型：Polyclonal
交叉反应：Human,Mouse,Rat,Dog,Pig,Cow,Rabbit,Sheep,
产品应用：WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test IF=1:100-500 （石蜡切片需做抗原修复）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
性 状：Liquid
浓 度：1mg/ml
免 疫 原：KLH conjugated synthetic peptide derived
亚 型：IgG
纯化方法：affinity purified by Protein A
储 存 液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存条件：Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
DCP异常凝血酶原/脱-γ-羧基凝血酶原抗体相关抗体示例（非本抗体，如需本抗体，请联系客服索要说明书）：
Sample:
Liver (Mouse) Lysate at 40 ug
Spleen (Mouse) Lysate at 40 ug
NIH/3T3 (Mouse) CellLysate at 30 ug
RAW246.7 (Mouse) CellLysate at 30 ug
Primary: Anti- IL12 at 1/300 dilution
Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
Predicted band size: 22 kD
Observed band size: 35/36 kD
paraffin embedded (Mouse brain); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (IL12) Polyclonal Antibody, Unconjugated at 1:400 overnight at 4°C, followed by operating according to SP Kit(Rabbit) instructions and DAB staining.
paraffin embedded (rat brain tissue); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (IL12) Polyclonal Antibody, Unconjugated at 1:400 overnight at 4°C, followed by operating according to SP Kit(Rabbit) instructionsand DAB staining.
DCP异常凝血酶原/脱-γ-羧基凝血酶原抗体
Blank control (blue line): Mouse spleen (blue).
Primary Antibody (green line): Rabbit Anti- IL12 antibody
Dilution: 1μg /10^6 cells;
Isotype Control Antibody (orange line): Rabbit IgG .
Secondary Antibody (white blue line): Goat anti-rabbit IgG-FITC
Dilution: 1μg /test.
Protocol
The cells were fixed with 70% ice-cold methanol overnight at 4℃. Cells stained with Primary Antibody for 30 min at room temperature. The cells were then incubated in 1 X PBS/2%BSA/10% goat serum to block non-specific protein-protein interactions followed by the antibody for 15 min at room temperature. The secondary antibody used for 40 min at room temperature. Acquisition of 20,000 events was performed.
Tissue/cell: rat colitis tissue; paraffin-embedded;
Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,at 37℃ for 20 min;
Incubation: Anti-IL-12 Polyclonal Antibody, Unconjugated 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB staining
欢迎新老客户咨询订购：DCP异常凝血酶原/脱-γ-羧基凝血酶原抗体
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验(凝血酶原)之间借Ca＋＋作为桥相连。因凝血酶原肽链的N�未端含有10个γ�羧基谷氨酸残基。相邻的羧基可与Ca＋＋形成复合体。另一方面，Ca＋＋又可与磷脂中磷酸基结合，这样使Xa和Va与凝血酶原接触在一起，于是Xa将凝血酶原水解为凝血酶(图10－6)。 图10－5 因子Xa激活凝血酶原示意图 图10－6 凝血酶的生成 凝血酶原及因子Ⅶ、Ⅺ、Ⅹ均由肝合成，合成过程中需要维素K作为辅因子。缺乏Vitk则生成异常凝血酶原，只有正常活性的1?%。研究表明Vitk
27.20%（0～100%），＜75%为肝癌诊断标准，阳性率86.0%，随病情恶化而降低。非癌肝病AFP-N-L为93.30±7.66%，假阳性率为1.6%。③异常凝血酶原：肝脏合成凝血酶原无活性前体，经维生素K，r羧化为活性形式。肝癌时，肝癌细胞的微粒体内维生素K依赖性羧化体系功能障碍，羟化酶活力下降，导致谷氨酸羧化不全，从而形成异常凝血酶原。最近人们发现肝癌细胞自由具有合成和释放异常凝血酶原的功能。国内用放射免疫自显影法测定异常凝血酶原≥250μg/L，为标准，肝癌阳性率为69.4%，AFP低浓度
凝血酶原是由肝脏合成的依赖维生素K的凝血因子。异常凝血酶原(Abnormal Prothrombin,APT)和凝血酶原的化学结构极其相似，区别在于：APT分子氨基端的特定位置上的谷氨酸残基未经羧基化，因而缺乏结合钙离子的结构基础，在一般凝血试验中无凝血活性。自从1984年Liebman等观察到原发性肝癌患者血浆APT水平显著升高，APT与肝癌的关系受到关注，其临床应用价值受到重视，测定方法不断改进。由于单克隆抗体建立的酶联法受外界因素影响小，可直接测出酶蛋白的含量，特异性强，灵敏
技术资料暂无技术资料 索取技术资料
